These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7491928)

  • 1. Transgenic animals in the study of blood pressure regulation and hypertension.
    Thompson MW; Merrill DC; Yang G; Robillard JE; Sigmund CD
    Am J Physiol; 1995 Nov; 269(5 Pt 1):E793-803. PubMed ID: 7491928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetics of primary hypertension.
    Ganten D; Schmidt S; Paul M
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S45-50. PubMed ID: 7700065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping of candidate genes for hypertension by fluorescence in situ hybridization on the genome of transgenic rats and mice.
    Schmidt C; Ganten D; Klenk A; Buselmaier W
    Clin Exp Hypertens; 1998 Feb; 20(2):185-204. PubMed ID: 9533613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney.
    Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS
    Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of blood pressure regulation and hypertension.
    Sugiyama F; Yagami K; Paigen B
    Curr Hypertens Rep; 2001 Feb; 3(1):41-8. PubMed ID: 11177707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Transgenic rats as a model for investigation of the pathogenesis of hypertension].
    Paul M
    Z Kardiol; 1995; 84 Suppl 4():55-60. PubMed ID: 8585274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive hypertension and end-organ damage in a transgenic mouse line carrying the rat angiotensinogen gene.
    Xu P; Wang Y; Sterner-Kock A; Bader M; Schultheiss HP; Walther T
    J Cardiovasc Pharmacol; 2009 Jan; 53(1):38-43. PubMed ID: 19129738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertension, kidney, and transgenics: a fresh perspective.
    Mullins LJ; Bailey MA; Mullins JJ
    Physiol Rev; 2006 Apr; 86(2):709-46. PubMed ID: 16601272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of blood pressure and the renin-angiotensin system in transgenic and spontaneously hypertensive rats afer ovariectomy.
    Bachmann J; Wagner J; Haufe C; Wystrychowski A; Ciechanowicz A; Ganten D
    J Hypertens Suppl; 1993 Dec; 11(5):S226-7. PubMed ID: 8158357
    [No Abstract]   [Full Text] [Related]  

  • 10. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes.
    Merrill DC; Thompson MW; Carney CL; Granwehr BP; Schlager G; Robillard JE; Sigmund CD
    J Clin Invest; 1996 Feb; 97(4):1047-55. PubMed ID: 8613528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney androgen-regulated protein transgenic mice show hypertension and renal alterations mediated by oxidative stress.
    Tornavaca O; Pascual G; Barreiro ML; Grande MT; Carretero A; Riera M; Garcia-Arumi E; Bardaji B; González-Núñez M; Montero MA; López-Novoa JM; Meseguer A
    Circulation; 2009 Apr; 119(14):1908-17. PubMed ID: 19332469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic basis of hypertension: progress and opportunities.
    Caulfield M; Collier D; O'Byrne S
    Hosp Med; 1998 Jan; 59(1):37-40. PubMed ID: 9798563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies towards a transgenic model of essential hypertension.
    Barrett GL; Mullins JJ
    Biochem Pharmacol; 1992 Mar; 43(5):925-30. PubMed ID: 1532493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Variability of plasma angiotensinogen levels and risk of hypertension in a transgenic rat model].
    Gudo B; Nussberger J; Bohlender J
    Ann Cardiol Angeiol (Paris); 2014 Jun; 63(3):124-7. PubMed ID: 24836939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation.
    Massiéra F; Bloch-Faure M; Ceiler D; Murakami K; Fukamizu A; Gasc JM; Quignard-Boulange A; Negrel R; Ailhaud G; Seydoux J; Meneton P; Teboul M
    FASEB J; 2001 Dec; 15(14):2727-9. PubMed ID: 11606482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of angiotensinogen in hepatocytes markedly decreases blood pressure in lean and obese male mice.
    Yiannikouris F; Wang Y; Shoemaker R; Larian N; Thompson J; English VL; Charnigo R; Su W; Gong M; Cassis LA
    Hypertension; 2015 Oct; 66(4):836-42. PubMed ID: 26303292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics in arterial hypertension--clinical and experimental aspects.
    Hübner N; Ganten D
    Herz; 1995 Oct; 20(5):309-14. PubMed ID: 7498877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transgenic animals in hypertension and cardiovascular research.
    Brosnan MJ; Mullins JJ
    Exp Nephrol; 1993; 1(1):3-12. PubMed ID: 8081950
    [No Abstract]   [Full Text] [Related]  

  • 19. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene.
    Mullins JJ; Peters J; Ganten D
    Nature; 1990 Apr; 344(6266):541-4. PubMed ID: 2181319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selection of candidate genes in hypertension.
    Mein CA; Caulfield MJ; Munroe PB
    Methods Mol Med; 2005; 108():107-29. PubMed ID: 16028679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.